Alk-Abello AS (OTCPK:AKBLF)
$ 22.05 -0.55 (-2.43%) Market Cap: 5.06 Bil Enterprise Value: 5.20 Bil PE Ratio: 42.97 PB Ratio: 6.73 GF Score: 86/100

Q2 2023 ALK-Abello A/S Earnings Call Transcript

Aug 24, 2023 / 11:30AM GMT
Release Date Price: $11.05
Per Plotnikof;S;VP of Corporate Communications;Carsten Hellmann;S;President
ALK-Abelló A;IR & Strategic Planning and Head of IR;ALK-Abelló A

/- -

Hello, everyone, and thank you all for joining this presentation of ALK's Q2 and half year results and the full year outlook. Let's turn to Slide 2, where I will introduce today's presenters and the agenda. My name is Per Plotnikof, I'm Head of Investor Relations. And with me today are CEO, Carsten Hellmann; and our new CFO, Claus Steensen Solje, who joined ALK on the first of June this year. Welcome on board, Claus.

Today, we will detail the performance in Q2 including market trends and financials. We will also provide an update on our strategic priorities, including a deep dive into the growth drivers for the respiratory tablet portfolio before we cover the full year outlook. As usual, we will end the call with a Q&A session.

To get started, I'll hand over to Carsten, who will elaborate on the highlights on Slide #3.

- /

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot